PosterSessionOnline

13th International Conference on Malignant Lymphoma

17-20 June 2015 Lugano

About us


Discussion forum - 13th International Conference on Malignant Lymphoma Topic - Mantle cell lymphoma If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER

Thread / Poster	Author	Replies	Last reply

Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP vs R-CHOP in the phase 3 LYM-3002 study	Gregor Verhoef	1	6/10/2015 4:17:00 PM


Clinical, metabolic and molecular responses with sequential R-CHOP, high-dose cytarabine, and iodine-131 tositumomab-based transplant in Mantle Cell Lymphoma	Anita Kumar	1	6/8/2015 8:30:00 PM


Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial	Michael Wang	1	6/8/2015 4:24:00 PM


Poor Overall Survival of Patients with Ibrutinib-Resistant Mantle Cell Lymphoma	Peter Martin	1	6/8/2015 3:35:00 AM


Multi-center phase II study with lenalidomide plus rituximab as initial treatment for mantle cell lymphoma: survival update and health-related quality-of-life analysis	Jia Ruan	1	6/7/2015 2:06:00 PM


Biological Rational for Sequential Targeting of Bruton Tyrosine Kinase and Bcl2 to Overcome Cd40-induced BH3-mimetics Resistance in Mantle Cell Lymphoma	David Chiron	1	6/5/2015 9:00:00 AM


High Dose Sequential Chemotherapy with Rituximab and ASCT as First Line Therapy in Adult MCL Patients: Clinical and Molecular Response of the MCL0208 Trial, a FIL Study.	Fabrizio Gallo	1	6/4/2015 6:41:00 PM


Most viewed poster for this congress

Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center


Poster most viewed in this topic

About us

Terms and Conditions

Special Access

Commercial Web Access